Larry J. Merlo's most recent trade in Kenvue Inc was a trade of 11,914 Deferred Share Units done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kenvue Inc | Larry J. Merlo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 11,914 | 39,374 | - | - | Deferred Share Units | |
| Kenvue Inc | Larry J. Merlo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 14,403 | 26,738 | - | - | Deferred Share Units | |
| Kenvue Inc | Larry J. Merlo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 11,854 | 11,854 | - | - | Deferred Share Units | |
| CVS Health Corp | Larry J. Merlo | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.44 per share. | 31 May 2021 | 634 | 632,312 (0%) | 0% | 86.4 | 54,803 | Common Stock |
| CVS Health Corp | Larry J. Merlo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2021 | 271,347 | 0 | - | - | Stock Option | |
| CVS Health Corp | Larry J. Merlo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.29 per share. | 26 Mar 2021 | 271,347 | 794,675 (0%) | 0% | 74.3 | 20,158,369 | Common Stock |
| CVS Health Corp | Larry J. Merlo | Director | Sale of securities on an exchange or to another person at price $ 74.73 per share. | 26 Mar 2021 | 270,650 | 524,025 (0%) | 0% | 74.7 | 20,225,675 | Common Stock |
| CVS Health Corp | Larry J. Merlo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 180,192 | 703,520 (0%) | 0% | 0 | Common Stock | |
| CVS Health Corp | Larry J. Merlo | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.30 per share. | 01 Feb 2021 | 81,700 | 622,517 (0%) | 0% | 74.3 | 6,070,310 | Common Stock |
| CVS Health Corp | Larry J. Merlo | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Feb 2021 | 8,651 | 632,946 (0%) | 0% | 0 | Common Stock | |
| CVS Health Corp | Larry J. Merlo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.29 per share. | 19 Jan 2021 | 64,350 | 586,221 (0%) | 0% | 74.3 | 4,780,562 | Common Stock |
| CVS Health Corp | Larry J. Merlo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 64,350 | 271,347 | - | - | Stock Option | |
| CVS Health Corp | Larry J. Merlo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 77.00 per share. | 19 Jan 2021 | 62,893 | 523,328 (0%) | 0% | 77 | 4,842,761 | Common Stock |